Biotech Values

[10nisman]

Thanks Dew for your help w/the messages boards. Definitely send an E-mail to Arlene regarding the GENR omission. Personally, I think Squalamine/GENR deserves to be mentioned. Maybe you can convince her to write up another AMD article including GENR once they start Phase III trials.

I have to admit I love seeing the buying by Osagie and the other directors. Maybe I'm just hopeful however, I get the feeling Osagie has the utmost confidence that GENR will strike a very lucrative partnership deal (partly because he knows how to strike a deal?)

Dew - Any revisions to your prediction on who GENR could/will partner up with? As mentioned earlier, MRK is most likely off the table.

Thanks for everyone's great responses...